心脏影像学用于慢性肾脏病患者冠心病风险分层
慢性肾脏病是冠心病的独立危险因素,患者心血管死亡率显著高于年龄和性别匹配的肾功能正常人群,且风险与肾功能损害程度包括微量白蛋白尿相关。该综述讨论了慢性肾脏病患者冠心病评估的最佳策略争议,以及严重肾功能不全限制碘对比剂和钆对比剂使用、广泛钙化限制CT血管成像诊断价值的情况下,超声心动图、非增强磁共振、核素心肌灌注和代谢成像等无肾毒性对比剂方法的应用价值。
要点
- 慢性肾脏病是冠心病独立危险因素,心血管死亡风险显著高于年龄和性别匹配的肾功能正常人群。
- 严重肾功能不全限制碘对比剂和钆对比剂使用,分别因对比剂肾病和肾源性系统性硬化风险。
- 许多慢性肾脏病患者存在与阻塞性冠心病严重程度不成比例的广泛过早钙化(常为内膜钙化),限制CT血管成像诊断价值。
核心结论
- 慢性肾脏病患者冠心病和死亡风险与肾功能损害程度相关,包括微量白蛋白尿的存在。
- 肾移植后心血管风险仍高于一般人群,但低于透析患者。
- 慢性肾脏病患者冠心病评估的最佳策略尤其是肾移植前评估,数十年来仍是争议话题。
- 超声心动图、非增强磁共振、核素心肌灌注和代谢成像可在无需肾毒性对比剂的情况下评估阻塞性冠心病和晚期慢性肾脏病心肌病。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
关键影像表现/征象
- 许多慢性肾脏病患者存在广泛且过早的钙化(常为内膜钙化),与阻塞性冠心病严重程度不成比例。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 严重肾功能不全限制放射学和磁共振对比剂使用,分别因对比剂肾病和肾源性系统性硬化风险。
- 许多慢性肾脏病患者广泛过早钙化与阻塞性冠心病严重程度不成比例,限制CT血管成像诊断价值。
- 慢性肾脏病患者冠心病评估最佳策略尤其是肾移植前评估仍为争议话题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Chronic kidney disease (CKD), defined as dysfunction of the glomerular filtration apparatus, is an independent risk factor for the development of coronary artery disease (CAD). Patients with CKD are at a substantially higher risk of cardiovascular mortality compared with the age- and sex-adjusted general population with normal kidney function. The risk of CAD and mortality in patients with CKD is correlated with the degree of renal dysfunction including presence of microalbuminuria. A greater cardiovascular risk, albeit lower than for patients receiving dialysis, persists even after kidney transplantation. Congestive heart failure, commonly caused by CAD, also accounts for a significant portion of the cardiovascular-related events observed in CKD. The optimal strategy for the evaluation of CAD in patients with CKD, particularly before renal transplantation, remains a topic of contention spanning over several decades. Although the evaluation of coexisting cardiac disease in patients with CKD is desirable, severe renal dysfunction limits the use of radiographic and magnetic resonance contrast agents due to concerns regarding contrast-induced nephropathy and nephrogenic systemic sclerosis, respectively. In addition, many patients with CKD have extensive and premature (often medial) calcification disproportionate to the severity of obstructive CAD, thereby limiting the diagnostic value of computed tomography angiography. As such, echocardiography, non-contrast-enhanced magnetic resonance, nuclear myocardial perfusion, and metabolic imaging offer a variety of approaches to assess obstructive CAD and cardiomyopathy of advanced CKD without the need for nephrotoxic contrast agents.
引用
- Dilsizian V, Gewirtz H, Marwick TH, et al. Cardiac Imaging for Coronary Heart Disease Risk Stratification in Chronic Kidney Disease. JACC Cardiovasc Imaging. 2020. PMID: 32828780. doi:10.1016/j.jcmg.2020.05.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。